Waterfall

CDC reports higher than expected frequency rate of chronic fatigue syndrome

by Richard Brassaw

In 1999, the Centers for Disease Control and Prevention (CDC) acknowledged that they had diverted millions of dollars, allocated by Congress, for research of chronic fatigue syndrome, to other research programs. Recently, the CDC released controversial studies that link CFS to to genetic mutations and abnormalities in key physiological processes. The CDC is also sponsoring [...]


Continue reading ' CDC reports higher than expected frequency rate of chronic fatigue syndrome' »


Fibromyalgia seen as a lucrative market

by Richard Brassaw

Research and Markets reports that fibromyalgia is a burgeoning market that will expand with an upsurge in diagnosis and treatments following the FDA’s approval of Lyrica as a treatment. In 2006 the market was estimated to be $367 million. They believe the market will continue to grow to $1.7 billion by 2016. The growth of [...]


Continue reading ' Fibromyalgia seen as a lucrative market' »


Parkinson’s and Alzheimer’s may be result of faulty blood protein system

by Richard Brassaw

Patients with Parkinson’s, Alzheimer’s, and Huntinton’s diseases have been found to have deposits of iron in their brain. It is thought that these ‘iron’ deposits are caused by the collapse of the transport system that safely moves iron through our blood stream. Peter Sadler, Professor, University of Warwick, and Sandeep Verma, Professor, Indian Institute of [...]


Continue reading ' Parkinson’s and Alzheimer’s may be result of faulty blood protein system' »


A potential treatment for Alzheimer’s fails clinical trail

by Richard Brassaw

Neurochem thought their Alzheimer’s disease drug, Alzhemed, would put them on the map with an anticipated annual sales of $4.5US billion. Clinical trials on Alzheimer’s patients in early to middle stages of the disease were tracked over an 18 month period. During that period the drug showed no discernible difference when compared to the group taking [...]


Continue reading ' A potential treatment for Alzheimer’s fails clinical trail' »


Dolphin ‘therapy’ dismissed as dangerous fad

by Richard Brassaw

Dolphin-assisted therapy (DAT) has been growing in popularity during the past decade. Part of its increase in popularity are the studies that claim people suffering from chronic mental or physical disabilities benefit from the dolphin “healing” experience. Lori Marino, Behavioral Biology Program, and Scott Lilienfeld, Department of Psychology, both of Emory University, reviewed 5 studies [...]


Continue reading ' Dolphin ‘therapy’ dismissed as dangerous fad' »


Alzheimer’s origins revealed in 3-D

by Richard Brassaw

The origins of Alzheimer’s disease is thought to be the result of A-beta peptide (Alzheimer’s peptide) when it clumps together in the brain and forms long fibrils. Whether it is the protein clumps or the fibrils that kill brain neurons is still being debated. Nikolaus Grigorieff, biophysicist, Brandeis University, along with researchers at Leibniz Institut, [...]


Continue reading ' Alzheimer’s origins revealed in 3-D' »